Nuzenio

Silexion Opens Its

Silexion Opens Its news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Timeline

Sun, 09 Aug 2026 13:24:56 GMTSilexion Therapeutics publishes corporate deck spotlighting SIL204 siRNA program targeting KRAS-driven cancers - Bitget
Wed, 05 Aug 2026 11:47:00 GMTCancer treatment makes tumor vulnerable to immune system attack, research finds - The Jerusalem Post
Tue, 04 Aug 2026 13:15:00 GMTSilexion Therapeutics Reports New Positive Preclinical - GlobeNewswire
Thu, 30 Jul 2026 07:00:00 GMTIsraeli scientists launch worlds-first clinical trial for experimental pancreatic cancer treatment - The Jerusalem Post
Wed, 29 Jul 2026 11:00:00 GMTSilexion Therapeutics Successfully Initiates Phase 2/3 - GlobeNewswire
Wed, 29 Jul 2026 07:00:00 GMTSilexion Opens Its First Pancreatic Cancer Trial Site in Israel - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Silexion Opens Its.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.